Grant Awards Cycle XV & XVI

Grant Awards in April & October 2006

Preface >>
Facts and Figures >>

Principal Investigator	Project Title/Link
1. Grant Awards in Cycle XV & XVI
1.1 Conventional Research Grants - Cycle XV
Dr Simi Ali University of Newcastle, Newcastle-upon-Tyne, UK	Non-Glycosaminoglycan-Binding Chemokine Receptor Agonists: A Novel Route to Anti-Rejection Therapy?
Dr Michael Autieri Temple University School of Medicine, Philadelphia, USA	The Role of Allograft-Inflammatory Factor-1 in Development of Graft Vascular Disease
Dr Anita S. Chong The University of Chicago, Chicago, USA	Bacterial Infections and Transplantation Tolerance
Dr Daniel Goldstein Yale University School of Medicine, New Haven, USA	Role of Innate B1 Lymphocytes in Neonatal Transplant Tolerance
Dr Gregg A. Hadley The Ohio State University, Columbus, USA	Mechanisms Underlying Immune Destruction of Pancreatic Islet Transplants
Dr Irma Joosten Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands	Effect of Regulatory T Cell Diversity on the Immune Response
Dr Karl Lemström University of Helsinki, Helsinki, Finland	Role of Hypoxia Inducible Factor-1 in Cardiac Allograft Vasculopathy
Dr Benjamin Medoff Massachusetts General Hospital, Boston, USA	The Role of the White Blood Cell Attractant CXCL10 in the Development of Lung Injury Following Lung Transplantation
Dr Hao Wang University of Western Ontario, London, Canada	Induction of Transplant Tolerance in Sensitized Recipients
Dr Li Zhang University of Maryland, Baltimore, USA	Integrin Mac-1 on Antigen-Presenting Cells Is Key to the Development of Peripheral Immune Tolerance

1.2 Conventional Research Grants - Cycle XVI
Dr Maria-Luisa Alegre The University of Chicago, Chicago, USA	Treg Specificity in a Mouse Cardiac Transplantation Tolerance Model
Dr Masato Imai Beth Israel Deaconess Medical Center, Boston, USA	NTPDase-1/CD39 Ameliorates Transplant Arteriosclerosis
Prof. James McCluskey The University of Melbourne, Parkville, Australia	Understanding Why Organ Transplants Are Rejected by the Host Immune System
Dr Wei-Ping Min University of Western Ontario, London, Canada	Protection of Donor Organs in Transplantation
Prof. Yorgo Modis Yale University, New Haven, USA	The Structural Basis of Innate Immune Sensing and Signaling by Toll-Like Receptors
Dr Julian Pratt Leeds University, Leeds, UK	Ischaemic Epigenetics in the Transplanted Kidney

1.3 Clinical Research Grants - Cycle XV
Dr Anthony Dorling Imperial College London, London, UK	Understanding How Antibodies and B Cells Contribute to the ‘Chronic’ Rejection of Transplanted Kidneys
Prof. Rudolphina J.M. ten Berge Academical Medical Center, Amsterdam, The Netherlands	Immunological Injury and Mechanisms of Self Defense in Subclinical Renal Allograft Rejection

1.4 Clinical Research Grants - Cycle XVI
Dr Henrik Petrowsky University Hospital Zurich, Zürich, Switzerland	Protective Mechanisms of Pentoxyfilline for Liver Surgery and Liver Transplantation
Dr Andrea Zachary Johns Hopkins University, Baltimore, USA	Detecting Humoral Sensitization

2. ROTRF/JDRF Joint Initiative Grant Awards
2.1 ROTRF/JDRF Joint Grant Awards - Cycle XVI
Dr Ariela Benigni Mario Negri Institute for Pharmacological Research, Bergamo, Italy	Generation of New Blood Vessels and Immunomodulation without Drugs to Improve Survival of Islet Grafts
Dr David M. Rothstein Yale University, New Haven, USA	How Experimental Agents Prevent Islet Transplant Rejection by Inducing Different Types of Regulatory T Cells
Dr Charmaine Simeonovic The Australian National University, Canberra, Australia	Immune Destruction and Protection of Pancreatic Islet Transplants

Print this page